| Title | Current Cancer Therapy Reviews |
| Abbreviation | Curr. Cancer Ther. Rev. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q4); Molecular Medicine (Q4); Oncology (Q4) |
| h-index | 19 |
| Overall Rank/Ranking | 20799 |
| SCImago Journal Rank (SJR) | 0.206 |
| Impact Score | 0.96 |
| Publisher | Bentham Science Publishers |
| Country | United Arab Emirates |
| ISSN | 18756301, 15733947 |
| Best Quartile | Q4 |
| Coverage History | 2006-2025 |
Current Cancer Therapy Reviews is a journal covering the technologies/fields/categories related to Cancer Research (Q4); Molecular Medicine (Q4); Oncology (Q4). It is published by Bentham Science Publishers. The overall rank of Current Cancer Therapy Reviews is 20799. According to SCImago Journal Rank (SJR), this journal is ranked 0.206. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 19. The best quartile for this journal is Q4.
The ISSN of Current Cancer Therapy Reviews journal is 18756301, 15733947. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Cancer Therapy Reviews is cited by a total of 82 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Current Cancer Therapy Reviews is 0.96, which is computed in 2025 as per its definition. Current Cancer Therapy Reviews IF is increased by a factor of 0.52 and approximate percentage change is 118.18% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Current Cancer Therapy Reviews is 0.96. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.96 |
| 2023 | 0.44 |
| 2022 | 0.54 |
| 2021 | 0.37 |
| 2020 | 0.25 |
| 2019 | 0.35 |
| 2018 | 0.22 |
| 2017 | 0.06 |
| 2016 | 0.25 |
| 2015 | 0.33 |
| 2014 | 0.31 |
Current Cancer Therapy Reviews has an h-index of 19. It means 19 articles of this journal have more than 19 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Current Cancer Therapy Reviews is 18756301, 15733947. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Current Cancer Therapy Reviews is 20799. According to SCImago Journal Rank (SJR), this journal is ranked 0.206. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.206 |
| 2023 | 0.172 |
| 2022 | 0.147 |
| 2021 | 0.117 |
| 2020 | 0.128 |
| 2019 | 0.128 |
| 2018 | 0.140 |
| 2017 | 0.140 |
| 2016 | 0.183 |
| 2015 | 0.159 |
| 2014 | 0.200 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 20799 |
| 2023 | 21607 |
| 2022 | 22099 |
| 2021 | 23566 |
| 2020 | 25603 |
| 2019 | 23679 |
| 2018 | 22339 |
| 2017 | 22083 |
| 2016 | 18829 |
| 2015 | 20286 |
| 2014 | 17153 |
Current Cancer Therapy Reviews is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2006-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Current Cancer Therapy Reviews is Curr. Cancer Ther. Rev.. This abbreviation ('Curr. Cancer Ther. Rev.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q4); Molecular Medicine (Q4); Oncology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Current Cancer Therapy Reviews latest impact IF is 0.96. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 0.96 (2024) and 0.06 (2017), respectively, in the last 11 years. Moreover, its average IS is 0.37 in the previous 11 years.
The Current Cancer Therapy Reviews has an SJR (SCImago Journal Rank) of 0.206, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.206 in 2024 and the lowest being 0.117 in 2021. Furthermore, the average SJR of the Current Cancer Therapy Reviews over the previous 11-year period stands at 0.37.
The latest h-index of the Current Cancer Therapy Reviews is 19.
The Current Cancer Therapy Reviews is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.
The Current Cancer Therapy Reviews is currently ranked 20799 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 17153 in 2014 and its lowest position of 25603 in 2020.
The standard ISO4 abbreviation for the Current Cancer Therapy Reviews is Curr. Cancer Ther. Rev..
Current Cancer Therapy Reviews is classified as a journal that the Bentham Science Publishers publishes.
The Current Cancer Therapy Reviews encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Current Cancer Therapy Reviews is assigned the following International Standard Serial Numbers (ISSN): 18756301, 15733947.
The best quartile for the Current Cancer Therapy Reviews is Q4 (2024).
The Current Cancer Therapy Reviews coverage history can be summarized as follows: 2006-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| European Union Politics | journal | 1953 | SAGE Publications Ltd | 79 | 3.71 |
| Qualitative Research | journal | 1300 | SAGE Publications Ltd | 101 | 6.77 |
| Clinical Medicine and Research | journal | 14921 | Marshfield Clinic | 64 | 1.25 |
| International Journal of Applied Linguistics | journal | 6655 | Wiley-Blackwell Publishing Ltd | 57 | 2.61 |
| European Journal of Education | journal | 4974 | Wiley-Blackwell Publishing Ltd | 63 | 5.08 |
| Transnational Corporations | journal | 13970 | UNCTAD United Nations Conference on Trade and Development | 30 | 1.63 |
| Palaeontographica Abteilung B: Palaeophytologie | book series | 10600 | Schweizerbart Science Publishers | 18 | 4.25 |
| Population Review | journal | 19550 | Sociological Demography Press | 15 | 0.59 |
| Physics and Chemistry of the Earth | journal | 12927 | Pergamon Press Ltd. | 33 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.96 |
| 2023 | 0.44 |
| 2022 | 0.54 |
| 2021 | 0.37 |
| 2020 | 0.25 |
| 2019 | 0.35 |
| 2018 | 0.22 |
| 2017 | 0.06 |
| 2016 | 0.25 |
| 2015 | 0.33 |
| 2014 | 0.31 |
